Saul Ewing LLP

About this office:

Saul Ewing LLP is a Mid-Atlantic law firm with 282 lawyers in eight offices in Pennsylvania, Maryland, New Jersey, Delaware, and the District of Columbia. Ingenuity, precision, and efficiency are the hallmarks of our more than eight decades of client service. Saul Ewing serves businesses throughout the United States and internationally, with a family of clients that includes major multinational corporations, preeminent regional businesses, exciting start-ups, and an array of privately held corporations. Saul Ewing's culture inspires our attorneys to become true counselors for our clients, anticipating their needs and helping them find creative solutions. Dedication to our clients and to the profession defines Saul Ewing. As active members of Interlex, an international association of law firms, Saul Ewing is also affiliated with law firms in over thirty-four foreign countries.

Bankruptcy and Restructuring, Brownfields, Business, Construction, Corporate Governance, Education, Employee Defection and Recruitment, Environmental, Health Law, Insurance, Labor, Employment and Employee Benefits, Life Sciences, Litigation (Commercial and Civil), Personal Wealth, Estates and Trusts, Public Finance, Real Estate, Securities, Tax, Technology, Emerging Companies and Capital, Technology Transactions and Intellectual Property, Telecommunications, White Collar Government Enforcement.

Advisory Committee Calls for Changes in "Deemed Export" Rules; Recommendations Could Have Widespread Impact on Nation's Universities and Research Centers
James M. Becker, James A. Keller, Jeffrey S. Levin, April 10, 2008
The U.S. Department of Commerce's Bureau of Industry and Security (BIS) publicly endorsed a report submitted by the Deemed Export Advisory Committee (DEAC) to that agency in the closing days of 2007. Composed primarily of representatives from many of the nation's leading universities and chaired by...

Another Federal District Court Rules That FDA Labeling Regulations Preempt Some State Law Tort Claims
Gregory J. Wartman, April 10, 2008
A federal district court in Oklahoma recently ruled that a plaintiff's state law failure to warn claims against a prescription drug manufacturer are preempted by FDA regulations because FDA had considered and expressly rejected the plaintiff's proposed additional warning.

District of Columbia Acts to Require Licenses for Pharmaceutical Sales Representatives
Bruce D. Armon, April 10, 2008
The District of Columbia enacted legislation requiring pharmaceutical sales representatives to be licensed by the D.C. Board of Pharmacy.

(For complete biographical data on other personnel, see Professional Biographies at Wilmington, Delaware; Wayne and Harrisburg, Pennsylvania; Newark and Princeton, New Jersey; Baltimore, Maryland; Washington, D.C.).

Return to the Saul Ewing LLP Firm Overview